BORGHI, MARIA ORIETTA
BORGHI, MARIA ORIETTA
Dipartimento di Scienze Cliniche e di Comunità
Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients
2023 P.L. Meroni, S. Croci, P.A. Lonati, F. Pregnolato, L. Spaggiari, G. Besutti, M. Bonacini, I. Ferrigno, A. Rossi, G. Hetland, I. Hollan, M. Cugno, F. Tedesco, M.O. Borghi, C. Salvarani
Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients
2023 R. Gualtierotti, S.E. Fox, F. Da Silva Lameira, A. Giachi, L.V.C. Valenti, M.O. Borghi, P. Luigi Meroni, M. Cugno, F. Payvandi
Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study
2023 A. Dicitore, G. Gaudenzi, S. Carra, M.C. Cantone, M. Oldani, D. Saronni, M.O. Borghi, J. Grotteschi, L. Persani, G. Vitale
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination
2022 P.A. Lonati, C. Bodio, M. Scavone, G. Martini, E. Pesce, A. Bandera, A. Lombardi, M. Gerosa, F. Franceschini, A. Tincani, G. Podda, S. Abrignani, R. Grifantini, M.N. Cattaneo, M.O. Borghi, P. Luigi Meroni
Role of epigenetic therapy in the modulation of tumor growth and migration in human castration-resistant prostate cancer cells with neuroendocrine differentiation
2022 A. Dicitore, M.G. Bacalini, D. Saronni, G. Gaudenzi, M.C. Cantone, G. Gelmini, E.S. Grassi, D. Gentilini, M.O. Borghi, A.M. Di Blasio, L. Persani, P. Garagnani, C. Franceschi, G. Vitale
Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
2022 D. Saronni, G. Gaudenzi, A. Dicitore, S. Carra, M.C. Cantone, M.O. Borghi, A. Barbieri, L. Mignani, L.J. Hofland, L. Persani, G. Vitale
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
2022 M.O. Borghi, M. Bombaci, C. Bodio, P.A. Lonati, A. Gobbini, M. Lorenzo, E. Torresani, A. Dubini, I. Bulgarelli, F. Solari, F. Pregnolato, A. Bandera, A. Gori, G. Parati, S. Abrignani, R. Grifantini, P.L. Meroni
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy
2021 G. Tosetti, E. Degasperi, E. Farina, R. D'Ambrosio, R. Soffredini, M. Borghi, V. La Mura, M. Primignani, P. Lampertico
Efficacy of a novel second-generation somatostatin-dopamine chimera (TBR-065) in human medullary thyroid cancer: a preclinical study
2021 A. Dicitore, M.C. Cantone, G. Gaudenzi, D. Saronni, S. Carra, M.O. Borghi, M. Albertelli, D. Ferone, L.J. Hofland, L. Persani, G. Vitale
Vandetanib versus cabozantinib in medullary thyroid carcinoma: A focus on anti‐angiogenic effects in zebrafish model
2021 S. Carra, G. Gaudenzi, A. Dicitore, D. Saronni, M.C. Cantone, A. Plebani, A. Ghilardi, M.O. Borghi, L.J. Hofland, L. Persani, G. Vitale
Histone deacetylase inhibitors ameliorate morphological defects and hypoexcitability of iPSC-neurons from Rubinstein-Taybi patients
2021 V. Alari, P. Scalmani, P.F. Ajmone, S. Perego, S. Avignone, I. Catusi, P.A. Lonati, M.O. Borghi, P. Finelli, B. Terragni, M. Mantegazza, S. Russo, L. Larizza
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
2021 G. Barturen, S. Babaei, F. Català-Moll, M. Martínez-Bueno, Z. Makowska, J. Martorell-Marugán, P. Carmona-Sáez, D. Toro-Domínguez, E. Carnero-Montoro, M. Teruel, M. Kerick, M. Acosta-Herrera, L. Le Lann, C. Jamin, J. Rodríguez-Ubreva, A. García-Gómez, J. Kageyama, A. Buttgereit, S. Hayat, J. Mueller, R. Lesche, M. Hernandez-Fuentes, M. Juarez, T. Rowley, I. White, C. Marañón, T. Gomes Anjos, N. Varela, R. Aguilar-Quesada, F.J. Garrancho, A. López-Berrio, M. Rodriguez Maresca, H. Navarro-Linares, I. Almeida, N. Azevedo, M. Brandão, A. Campar, R. Faria, F. Farinha, A. Marinho, E. Neves, A. Tavares, C. Vasconcelos, E. Trombetta, G. Montanelli, B. Vigone, D. Alvarez-Errico, T. Li, R. Blanco Alonso, A. Corrales Martínez, F. Genre, R. López Mejías, M.A. Gonzalez-Gay, S. Remuzgo, B. Ubilla Garcia, R. Cervera, G. Espinosa, I. Rodríguez-Pintó, E. De Langhe, J. Cremer, R. Lories, D. Belz, N. Hunzelmann, N. Baerlecken, K. Kniesch, T. Witte, M. Lehner, G. Stummvoll, M. Zauner, M.A. Aguirre-Zamorano, N. Barbarroja, M.C. Castro-Villegas, E. Collantes-Estevez, E. de Ramon, I. Díaz Quintero, A. Escudero-Contreras, M.C. Fernández Roldán, Y. Jiménez Gómez, I. Jiménez Moleón, R. Lopez-Pedrera, R. Ortega-Castro, N. Ortego, E. Raya, C. Artusi, M. Gerosa, P. Luigi Meroni, T. Schioppo, A. De Groof, J. Ducreux, B. Lauwerys, A. Maudoux, D. Cornec, V. Devauchelle-Pensec, S. Jousse-Joulin, P. Jouve, B. Rouvière, A. Saraux, Q. Simon, M. Alvarez, C. Chizzolini, A. Dufour, D. Wynar, A. Balog, M. Bocskai, M. Deák, S. Dulic, G. Kádár, L. Kovács, Q. Cheng, V. Gerl, F. Hiepe, L. Khodadadi, S. Thiel, E. de Rinaldis, S. Rao, R.J. Benschop, C. Chamberlain, E.R. Dow, Y. Ioannou, L. Laigle, J. Marovac, J. Wojcik, Y. Renaudineau, M.O. Borghi, J. Frostegård, J. Martín, L. Beretta, E. Ballestar, F. Mcdonald, J. Pers, M.E. Alarcón-Riquelme
Complement activation and endothelial perturbation parallel COVID-19 severity and activity
2021 M. Cugno, P.L. Meroni, R. Gualtierotti, S. Griffini, E. Grovetti, A. Torri, P. Lonati, C. Grossi, M.O. Borghi, C. Novembrino, M. Boscolo, S.C. Uceda Renteria, L. Valenti, G. Lamorte, M. Manunta, D. Prati, A. Pesenti, F. Blasi, G. Costantino, A. Gori, A. Bandera, F. Tedesco, F. Peyvandi
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
2021 F. Pregnolato, M. Gerosa, M.G. Raimondo, C. Comerio, F. Bartoli, P.A. Lonati, M.O. Borghi, B. Acaia, M.W. Ossola, E. Ferrazzi, L. Trespidi, P.L. Meroni, C.B. Chighizola
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors
2020 C. Bodio, C. Grossi, F. Pregnolato, E.G. Favalli, M. Biggioggero, A. Marchesoni, A. Murgo, M. Filippini, P. Migliorini, R. Caporali, R. Pellerito, F. Ciccia, P. Sarzi-Puttini, F. Perosa, G. Paolazzi, I. Hollan, K. Bendtzen, P.L. Meroni, M.O. Borghi
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome
2019 P.A. Lonati, M. Scavone, M. Gerosa, M.O. Borghi, F. Pregnolato, D. Curreli, G. Podda, E.A. Femia, W. Barcellini, M. Cattaneo, F. Tedesco, P.L. Meroni
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications
2018 F. Tedesco, M.O. Borghi, M. Gerosa, C.B. Chighizola, P. Macor, P.A. Lonati, A. Gulino, B. Belmonte, P.L. Meroni
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome
2018 C.B. Chighizola, F. Pregnolato, L. Andreoli, C. Bodio, L. Cesana, C. Comerio, M. Gerosa, C. Grossi, R. Kumar, M.G. Lazzaroni, M. Mahler, E. Mattia, C. Nalli, G.L. Norman, M.G. Raimondo, A. Ruffatti, M. Tonello, L. Trespidi, A. Tincani, M.O. Borghi, P.L. Meroni
Successful sequential therapy with rituximab and belimumab in patients with active systemic lupus erythematosus: a case series
2018 R. Gualtierotti, M.O. Borghi, M. Gerosa, T. Schioppo, P. Larghi, J. Geginat, P.L. Meroni
The Efficacy of Treatment with Low Dose Aspirin and Low Molecular Weight Heparin in Pregnant Women with Criteria Anti-Phospholipid Antibodies
2018 C. Chighizola, F. Pregnolato, M. Raimondo, C. Comerio, L. Trespidi, M. Borghi, M. Gerosa, B. Acaia, W. Ossola, E. Ferrazzi, A. Bulfoni, P. Meroni